Study of Merozoite Surface Protein-1 Variants in Malaria
Author Information
Author(s): Mamillapalli Anitha, Sunil Sujatha, Diwan Suraksha S, Sharma Surya K, Tyagi Prajesh K, Adak Tridibes, Joshi Hema, Malhotra Pawan
Primary Institution: National Institute for Malaria Research, New Delhi, India
Hypothesis
Does the sequence heterogeneity of PfMSP-1 lead to variation in naturally acquired anti-MSP-119 antibodies?
Conclusion
The study shows that allele specific antibodies exist in P. falciparum-infected patients, indicating the need for a multi-allelic PfMSP-119 based vaccine for effective malaria control.
Supporting Evidence
- The study identified seven PfMSP-119 variant forms in a single geographical location.
- Predominance of the PfMAD20 allele was observed among Indian field isolates.
- Cross-reactive and variant-specific antibodies were found in patient sera.
Takeaway
This study looked at different versions of a protein from malaria parasites in Indian patients and found that people have different antibodies against these versions, which is important for making a good vaccine.
Methodology
The study involved collecting blood samples from malaria patients, determining sequence variations in the PfMSP-119 gene, and conducting immunodepletion assays.
Limitations
The study only expressed and analyzed three PfMSP-119 variants, which may not represent all variants present in the population.
Participant Demographics
Patients aged between six months to 17 years from malaria-endemic villages in eastern India.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website